Unusually high numbers of U.S. lymphoma patients are choosing experimental treatments over expensive cell therapies sold by Gilead Sciences Inc and Novartis AG, new data shows, helping explain why sales of the two products have not met rosy expectations.
from Reuters: U.S. https://ift.tt/2ynLgm9
Tuesday 30 July 2019
Popular Posts
-
The U.S. Senate voted by a 52 to 40 vote on Wednesday to confirm former Delta Air Lines executive Stephen Dickson to head the Federal Aviati...
-
FORT LAUDERDALE, Fla. (Reuters) - A former student accused of last week's deadly shooting at a Florida high school returned to court for...
-
WASHINGTON (Reuters) - U.S. Supreme Court justices on Wednesday appeared conflicted over what to do -- if anything -- to rein in politicians...
-
Opposition MPs demand an inquiry after a religious body implies girls as young as nine could marry. from BBC News - World http://ift.tt/2C...
Categories
About Me
- Ankit Chandwada
- i am a young indian blogeer and i work to change my dreams into reality, This is my blog allinonetricks
0 comments:
Post a Comment